内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Ridloff Elena. Officer active across 4 companies, notably Kronos Bio, Inc.. Cumulatively, 13 filings have been recorded. Split: 0 buy · 6 sells. Total volume traded: €1.6m. History available since 22 June 2023. The latest transaction was filed on 1 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Ridloff Elena
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
7,400 股@ US$14.188.2% 占其流量Common StockSEC:0001193125-26-138372:0
7,400 股@ US$85.370149.1% 占其流量Common StockSEC:0001193125-26-138372:1
4,600 股@ US$14.185.1% 占其流量Common StockSEC:0001193125-26-138372:2
3,400 股@ US$85.194622.5% 占其流量Common StockSEC:0001193125-26-138372:3
1,200 股@ US$86.058.0% 占其流量Common StockSEC:0001193125-26-138372:4
748 股@ US$25.18Common StockSEC:0002036042-25-000053:0
3,700 股@ US$25.13Common StockSEC:0002036042-25-000050:0
34,500 股@ US$21.08100.0% 占其流量Common StockSEC:0001482981-25-000143:0
25,296 股@ US$0.57100.0% 占其流量Common StockSEC:0001415889-25-017835:0
4,500 股@ US$20.29100.0% 占其流量Common StockSEC:0000950170-25-084893:0
12,000 股@ US$27.67100.0% 占其流量Common StockSEC:0000950170-25-081200:0
11,333 股0Common StockSEC:0001415889-24-018239:0
11,333 股0Common StockSEC:0001209191-23-039696:0
About Ridloff Elena
Ridloff Elena is a declarant and is listed as a director of Kymera Therapeutics, Inc. and Kronos Bio, Inc. She has 10 filings in total. Across the 10 sampled filings, from 2023-06-26 to 2026-04-01, sells total 884817 EUR and the most frequent transaction nature is Levée d'options.